# Neo Biotech to invest $26M in new headquarters and plant in Wonju, South Korea

Neo Biotech signed an investment agreement to relocate its headquarters, production facilities, and research institute to Wonju Corporate City, investing 31 billion won ($26 million) and creating 289 jobs.

- Type: Investment
- Announced: 2019-12-19
- Where: Wonju, Gangwon Province, South Korea
- Value: $26.0M (31.0B KRW)
- Jobs: 289
- Starts operating: May 2024
- Status: announced
- Products: dental implants, dental medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Neo Biotech](https://endata.com/companies/44036.md)

## Sources

- [yna.co.kr](https://www.yna.co.kr/view/AKR20191219117400062), 2019-12-19: "This company will relocate its headquarters, production facilities, and research institute to Wonju Corporate City."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.